CD8A and neoplasm: Using a more solid DT6606 tumor model, we observed that VV pre-immunized mice had the highest number of tumor infiltrating of CD8+ effector memory T cells (TEM), but fewer CD8+ central memory T cells (TCM) 21 days after the last VV i.t. injection (Figure S4), possibly due to a recruitment of TCM as TEM post-VV treatment.